Does anybody here have information on RLYP's Valtessa sales for the last two weeks?
It seems silly for RLYP to be trading at 1/3rd of ZSPH's market cap when it has the approved drug and ZSPH does not. ZSPH's drug approval is not 100% guaranteed.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.